| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |